Sponsored Links
| PerkinElmer And The Meyer Children's Hospital Of Florence Co-Develop Early Diagnostic For Lethal Genetic Metabolic Disease Affecting Newborns |
 |
 |
 |
| Medical News - Genetics | |||
|
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, and the Meyer Children's Hospital of Florence, a leading Italian research center, today announced their successful collaboration in developing an early stage neonatal diagnostic test for Tyrosinemia Type I, a rare metabolic genetic disease that is lethal if untreated, but curable if detected early... Read more: Genetics News From Medical News Today
|